1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ivanhoe Electric entered into an Amended and Restated Shareholders Agreement on July 7, 2026, governing its 50/50 exploration joint venture with Saudi Arabian Mining Company (Maaden). The amended agreement changes how the joint venture acquires land, approves budgets and contracts, and handles future mining projects, and extends the exploration term to July 6, 2033. The filing does not report any financial results or a dollar value for the changes, so the effect on shareholders is not quantified.
Joint venture exploration term extended ten years from the effective date, now ending July 6, 2033
Joint venture board approval now needed only for hiring or firing certain senior executives, with a 75% shareholder threshold for reserved matters such as contracts of $2 million or more
Company remains operator during exploration; Maaden assumes operatorship if a deposit is designated for development
Company originally contributed $66 million to fund the joint venture
Caesars Entertainment director Courtney Mather has resigned from the company's Board of Directors, effective July 6, 2026, according to an 8-K filed July 7, 2026. The filing states the resignation is not the result of any disagreement with the company.
Courtney Mather resigned from the Board of Directors effective July 6, 2026.
Mather informed the Executive Chairman of the Board of his decision on July 6, 2026.
The filing states the resignation is not due to any disagreement with the company.
Cartesian Growth Corporation IV, a blank check company, closed its initial public offering of 27,500,000 units at $10.00 per unit on June 26, 2026, generating $275 million in gross proceeds, and placed the full $275 million in a trust account. The company has not yet selected a business combination target, so public shareholders' funds remain in the trust until a deal is completed or the company liquidates.
IPO of 27,500,000 units at $10.00 per unit, including 2,500,000 units from partial exercise of the underwriters' over-allotment option, for $275,000,000 in gross proceeds
$275,000,000 ($10.00 per unit) placed in a trust account with Continental Stock Transfer & Trust Company as trustee
Private placement of 2,500,000 warrants at $2.00 each to CGC IV Sponsor LLC and Cantor Fitzgerald & Co. for $5,000,000 in gross proceeds
The company has not selected a target and has 24 months from the IPO closing to complete a business combination
Civeo completed a private offering of $100 million in 4.50% convertible senior notes due 2031 on July 7, 2026, with an option for initial purchasers to buy up to an additional $15 million. The company used about $22.3 million of the net proceeds to repurchase 660,297 common shares and plans to use the rest to repay borrowings under its syndicated facility agreement.
Notes carry a 4.50% interest rate, payable semi-annually, and mature August 1, 2031
Net proceeds of about $96.2 million, after discounts and offering expenses
Initial conversion price of about $40.51 per common share; maximum of 2,962,080 shares issuable, or 3,406,392 if the option is fully exercised
Company may not redeem the notes before August 1, 2029, except for tax or cleanup redemptions
ResMed agreed on June 30, 2026 to sell its MatrixCare business to private equity firm Frazier Healthcare Partners for $490 million in cash, subject to closing adjustments. The company plans to use the proceeds to return capital to shareholders, including an accelerated share repurchase, and for general corporate purposes. The filing reiterates ResMed's fiscal 2026 outlook and says the full fiscal 2027 outlook will be given on August 6, 2026.
Buyer is Frazier Healthcare Partners; price is $490 million all-cash, subject to certain closing adjustments.
Deal is expected to close in the first quarter of fiscal 2027, subject to regulatory approvals and customary conditions.
MatrixCare had approximately $220 million of revenue and $55 million of non-GAAP operating profit in fiscal 2026, based on preliminary results.
Recently completed Noctrix acquisition is expected to add about $30 million of fiscal 2027 revenue and reduce non-GAAP diluted EPS by about $0.20.
Goldman Sachs BDC said it will report second quarter 2026 financial results after the market closes on Thursday, August 6, 2026, and hold an earnings conference call on Friday, August 7, 2026 at 9:00 am Eastern Time. The announcement is a scheduling notice and does not contain financial results.
Second quarter ended June 30, 2026 results to be released after market close on August 6, 2026
Earnings conference call set for 9:00 am Eastern Time on August 7, 2026
Listen-only and Q&A dial-in numbers provided, with an archived replay on the company website
CareDx completed the sale of its Lab Products business to Eurobio Scientific on June 30, 2026, and the acquisition of Naveris, maker of the NavDx cancer test, on July 1, 2026. The company will include Naveris in its consolidated results from the third quarter of 2026, and it plans to give financial impact details on the sale during its second quarter 2026 earnings call.
Eurobio sale closed June 30, 2026; the 8-K reports $171.7 million in cash, subject to customary adjustments, while the press release cites $171.2 million at closing.
Naveris acquisition closed July 1, 2026, for $161.8 million in cash, subject to adjustments, plus up to $100.0 million in contingent cash tied to 2026 and 2027 revenue milestones.
The press release says Naveris generated approximately $35 million in revenue in 2025 and that NavDx has Medicare coverage for HPV-driven head and neck and anal cancer MRD testing.
Financial statements of Naveris and pro forma information will be filed by amendment within 71 calendar days.
Iridium completed its acquisition of the remaining 61% of Aireon Holdings LLC on July 2, 2026, giving it full ownership of Aireon. The purchase price was approximately $366.7 million, with half paid in cash and the rest funded by a $183.36 million interest-free loan from the sellers, while Aireon's $154.7 million term loans now sit on Iridium's consolidated balance sheet. The filing also discloses cash retention awards for two executives tied to the pending Rocket Lab merger.
Purchase price of approximately $366.7 million, 50% paid in cash at closing on July 2, 2026
Sellers provided a $183.36 million interest-free term loan maturing one year after the closing date
Aireon's Term Loans had an aggregate principal balance of $154.7 million, maturing October 10, 2028
CFO Vincent J. O'Neill ($409,999.98) and CLO Kathleen A. Morgan ($873,036.32) received retention awards tied to the Rocket Lab merger agreement dated June 28, 2026
Oceaneering completed a private placement of $500 million of 6.875% senior notes due July 15, 2034 on July 6, 2026, and amended its senior secured revolving credit facility the same day. The notes satisfied the financing condition for a previously announced cash tender offer, and the amendment raised revolver commitments and extended their maturity, which the company says provides additional financial flexibility.
$500 million of 6.875% senior notes due July 15, 2034, sold to qualified institutional and non-U.S. buyers on July 6, 2026
Interest payable January 15 and July 15 each year, starting January 15, 2027; notes are unsecured senior obligations
Revolving credit commitments increased from $215 million to $345 million; maturity extended from 2027 to 2031
Financing condition for the cash tender offer described in the June 24, 2026 Offer to Purchase was satisfied on July 6, 2026
Praxis Precision Medicines entered a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide, its essential tremor candidate. The company also made an equity investment in Remagine, and says the transdermal option could broaden the patient population and strengthen the drug's competitive position.
Agreement announced July 7, 2026, with Remagine Labs, Inc., a developer of electronically controlled transdermal drug delivery systems
Remagine's platform is designed for precise, multi-day active transdermal dosing of ulixacaltamide for essential tremor
Praxis made an equity investment in Remagine; the filing does not disclose the amount or financial terms
The patch is intended to complement the company's lead oral program for ulixacaltamide
UGI Energy Services, a wholly owned subsidiary of UGI, entered into a Fourth Amendment to its credit agreement on June 30, 2026, with HSBC Bank USA as administrative agent and as 2026 Refinancing Term Lender. The amendment sets the Applicable Rate at 2.00% per annum for SOFR loans and 1.00% for base rate loans. The filing is a routine refinancing update and does not report financial results or shareholder-level changes.
Amendment dated June 30, 2026, to the credit agreement originally dated August 13, 2019
Applicable Rate set at 2.00% per annum for SOFR loans and 1.00% per annum for base rate loans
HSBC Bank USA, N.A. serves as administrative agent and 2026 Refinancing Term Lender
Global Industrial Company and its subsidiaries signed Amendment No. 4 to their credit agreement with JPMorgan Chase Bank, N.A. on June 30, 2026. The amendment extends the facility's maturity date from October 19, 2026 to June 30, 2031, pushing the repayment deadline out about five years.
Amendment No. 4 dated June 30, 2026, amends the Third Amended and Restated Credit Agreement from October 28, 2016.
Maturity date moves from October 19, 2026 to June 30, 2031.
JPMorgan Chase Bank, N.A. is administrative agent, sole bookrunner and sole lead arranger.
Public Storage's Chief Operating Officer, Chris Sambar, resigned effective at the end of July 2026 to become Chief Enterprise Officer at T-Mobile. The company said the departure was not related to any disagreement over its operations, policies, or practices, and that operations leadership will report to CEO Tom Boyle until a permanent replacement is named.
Chris Sambar resigned on July 2, 2026, effective at the end of July 2026
He is joining T-Mobile as Chief Enterprise Officer
No disagreement with the company on operations, policies, or practices, according to the filing
Operations leadership will report directly to CEO Tom Boyle until a permanent replacement is identified
Quaker Houghton's Vice President, Corporate Controller and Principal Accounting Officer, Steven Dassing, resigned on June 30, 2026, effective July 22, 2026, to pursue another career opportunity, and the company says the resignation is not the result of any dispute. Executive Vice President and Chief Financial Officer Mr. Coler will also take on the Principal Accounting Officer role when Dassing's resignation takes effect, with no new compensatory arrangements.
Steven Dassing resigned as VP, Corporate Controller and Principal Accounting Officer on June 30, 2026, effective July 22, 2026
Dassing plans to pursue another career opportunity; the company states no dispute or disagreement was involved
CFO Mr. Coler, age 53, will serve as Principal Accounting Officer in addition to his CFO role
No new compensatory arrangements were entered into with Mr. Coler for the added role
MasTec entered a $700 million delayed draw term loan to help fund its planned acquisition of Electrical Specialists, Inc., d/b/a the Superior Group, and expanded its revolving credit commitments by $350 million to $2,250 million. The company also agreed to issue about 1,195,721 shares, valued at about $475 million, as partial acquisition consideration, which the filing says represents about 1.5% of outstanding shares.
Delayed draw term loan of $700 million: $400 million three-year tranche and $300 million four-year tranche, with Bank of America as administrative agent.
Revolving credit commitments increased by $350 million to an aggregate $2,250 million.
About 1,195,721 consideration shares valued at about $475,000,000, roughly 1.5% of outstanding shares after issuance, expected to close in the third quarter of 2026.
Director Manuel Benito Miranda appointed to the Board effective June 30, 2026, and to the Compensation Committee.
21Shares US LLC, the sponsor of the 21Shares Sui ETF, gave CF Benchmarks notice on June 30, 2026 that it is terminating the licensing agreement for the CME CF Sui Dollar Reference Rate, effective August 31, 2026. The sponsor plans to license FTSE index data on or about August 24, 2026, as part of a broader move to a new benchmark provider. Because the benchmark is used to value the trust's shares daily and to calculate net asset value, shareholders will be affected by this change of provider.
Sponsor gave termination notice to CF Benchmarks on June 30, 2026, effective August 31, 2026
Terminated agreement covers the CME CF Sui Dollar Reference Rate, New York Variant, used to value shares and calculate NAV
Sponsor intends to enter a licensing agreement with FTSE International Limited on or about August 24, 2026
FTSE license is expected to have a one-year initial term that renews automatically
The fund's sponsor, 21Shares US LLC, gave notice on June 30, 2026 that it is terminating its licensing agreement with CF Benchmarks, effective August 31, 2026. The benchmark is used to value the Trust's shares daily and calculate its net asset value, so the change affects how the fund is priced. The sponsor plans a replacement license with FTSE International Limited on or about August 24, 2026.
Notice of termination given to CF Benchmarks Ltd. on June 30, 2026, effective August 31, 2026.
Terminated agreement covers the CME CF Solana-Dollar Reference Rate - New York Variant, used to value shares daily and calculate net asset value.
Sponsor intends to license FTSE index data from FTSE International Limited on or about August 24, 2026, with a one-year initial term.
The sponsor of the ARK 21Shares Bitcoin ETF gave notice on June 30, 2026 that it will terminate its licensing agreement with CF Benchmarks, effective August 31, 2026. The fund uses the CME CF Bitcoin Reference Rate to value its shares daily and calculate net asset value, so it plans to replace it with FTSE index data under a new license expected around August 24, 2026.
Termination notice given to CF Benchmarks on June 30, 2026, effective August 31, 2026
Pricing benchmark being replaced is the CME CF Bitcoin Reference Rate—New York Variant
Sponsor intends to sign a new license with FTSE International Limited on or about August 24, 2026
Filing says the switch is part of a broader transition to a new benchmark provider; no financial impact figures are given
The Sponsor, 21Shares US LLC, notified CF Benchmarks on June 30, 2026 that it is terminating the licensing agreement for the XRP pricing benchmark used to value the Trust's shares and calculate its net asset value, effective August 31, 2026. The Sponsor plans to replace it with a licensing agreement with FTSE International Limited on or about August 24, 2026, as part of a broader move to a new benchmark provider.
Notice of termination given to CF Benchmarks on June 30, 2026; termination effective August 31, 2026
Terminated agreement covers the CME CF XRP-Dollar Reference Rate, New York Variant, used daily for share valuation and NAV
Sponsor intends to license FTSE index data on or about August 24, 2026, with a one-year initial term that renews automatically
Suncrete's borrowing unit amended its Bank of America credit agreement on June 30, 2026, adding a $175.0 million delayed draw term loan and raising the revolving credit facility from $25.0 million to $50.0 million. The amendment also permits up to $400.0 million in net cash proceeds from equity issuances to fund permitted acquisitions and changes certain financial covenants.
Delayed draw term loan of $175.0 million available for drawings until December 31, 2027 or earlier termination, maturing July 29, 2029
Revolving credit facility increased from $25.0 million to $50.0 million; about $22.0 million outstanding as of June 30, 2026 after a roughly $7.0 million drawdown that day
Term loan outstanding was about $189.2 million after application of amendment proceeds; no delayed draw borrowings had been made as of the Effective Date
Senior net leverage covenant set at 4.00-to-1.00 through June 30, 2027, then 3.50-to-1.00 after September 30, 2027
Osprey Acquisition Corp. III, a blank check company, completed its initial public offering on July 2, 2026, selling 30,015,000 units at $10.00 each for gross proceeds of $300,150,000, including full exercise of the over-allotment option. The full $300,150,000 was placed in a trust account for public shareholders, and funds will generally not be released until a business combination, or redemption if none is completed within 24 months.
IPO of 30,015,000 units at $10.00 per unit, gross proceeds of $300,150,000, closed July 2, 2026
Private placement of 747,000 units to Cantor and the sponsor for gross proceeds of $7,470,000
Trust account funded with $300,150,000; funds generally held until a business combination or 24-month deadline
Board expanded to include Daniel C. Herz, Jonathan Z. Cohen and others; Jeffrey F. Brotman resigned from the board
The sponsor, 21Shares US LLC, gave CF Benchmarks notice on June 30, 2026 that it is terminating the licensing agreement for the CME CF Ether-Dollar Reference Rate used to value the trust's shares and calculate its net asset value. The sponsor intends to replace it with a license from FTSE International Limited on or about August 24, 2026, as part of a broader move to a new benchmark provider.
Termination of the CF Benchmarks pricing benchmark license is effective August 31, 2026
Notice to CF Benchmarks was provided June 30, 2026
Sponsor intends to enter a FTSE International Limited license on or about August 24, 2026, with a one-year initial term that auto-renews
The benchmark is used daily to value trust shares and calculate net asset value
Unitil Corporation completed its purchase of Aquarion Water Company of New Hampshire and Abenaki Water Co. from the Aquarion Water Authority on June 30, 2026. The purchase price was $55.8 million, including about $13.7 million of assumed debt, and the company funded it with a term loan from Scotiabank under an amended and restated credit agreement. The company said the acquisition is expected to be earnings accretive over the long term, but the filing gives no figures for near-term results.
The acquired systems include about 150 miles of water distribution mains and serve about 11,000 customers in eight New Hampshire communities.
Purchase price was $55.8 million, including $13.7 million of assumed debt, plus about $0.6 million for estimated working capital and reimbursable capital expenditures.
The credit agreement includes a $50.0 million Tranche B loan for these acquisitions, with amounts due June 30, 2027; Unitil borrowed $42.7 million on June 30, 2026.
Amendment No. 4, dated June 30, 2026, limited the purchase to Aquarion Water Company of New Hampshire and Abenaki Water Co.
T-Mobile appointed Chris Sambar, formerly Chief Operating Officer at Public Storage and a two-decade AT&T veteran, as Chief Enterprise Officer, effective no later than October 14, 2026. Chief Business and Product Officer Michael J. Katz is leaving his role effective July 8, 2026, and will remain as a strategic advisor through December 2026. The filing reports no financial results, so the changes affect shareholders through leadership structure rather than current numbers.
Chris Sambar joins as Chief Enterprise Officer, effective no later than October 14, 2026, reporting to CEO Srinivasan Gopalan
Michael J. Katz, Chief Business and Product Officer, steps away effective July 8, 2026, and stays as strategic advisor through December 2026
André Almeida moves to Chief Marketing, Brand and Broadband Officer; Dr. John Saw expands his role to include product engineering and cybersecurity
The sponsor of the 21Shares Dogecoin ETF (TDOG) gave notice on June 30, 2026 that it will terminate its licensing agreement with CF Benchmarks, effective August 31, 2026. The index is used to value the trust's shares daily and calculate its net asset value, so the change affects how the fund is priced; the sponsor plans a replacement license with FTSE International Limited on or about August 24, 2026.
Notice of termination given to CF Benchmarks on June 30, 2026; termination effective August 31, 2026
Terminated agreement covers the CF Dogecoin-Dollar US Settlement Price Index, used to value shares and calculate net asset value
Sponsor intends to license FTSE index data on or about August 24, 2026, with a one-year initial term that renews automatically
RPC, Inc. entered into an Amended and Restated Credit Agreement dated June 30, 2026, with Bank of America, N.A. as administrative agent, covering a revolving line of credit of up to $100 million. The amendment extends the termination date for revolving loans from June 22, 2027 to June 30, 2031 and removes the SOFR Adjustment from pricing, which gives the company a longer borrowing window on the stated terms.
Revolving line of credit of up to $100 million, including a $35 million letter of credit sub-facility and a $35 million swingline sub-facility
Termination date for revolving loans extended from June 22, 2027 to June 30, 2031
SOFR Adjustment (10 to 25 basis points under the prior terms) removed from pricing
Agreement dated June 30, 2026; 8-K filed July 7, 2026, signed by CFO Michael L. Schmit
LifeStance Health Group said director Jeffrey Rhodes resigned from the board and all its committees effective immediately, and that the resignation was not due to any disagreement with the company. The board appointed Thurman Justice, Lori Goltermann and Safwan Shabab as directors to fill vacancies, a board change that is administrative in nature and carries no stated financial effect.
Jeffrey Rhodes resigned from the board and all committees effective immediately, notified July 2, 2026
Thurman Justice and Lori Goltermann appointed Class II directors, serving until the 2029 annual meeting
Safwan Shabab appointed Class III director under a June 9, 2021 stockholder agreement, serving until the 2027 meeting
Justice and Goltermann each received an initial award of 35,492 restricted stock units under the 2021 Equity Incentive Plan
Yext's board increased its size from seven to eight directors and elected Cynthia Paul, founder and CEO of investment firm Lynrock Lake LP, to fill the new seat as a Class I member. Her term runs to the 2027 annual meeting, and she receives standard outside director compensation including an initial restricted stock unit grant valued at $350,000.
Board expanded from seven to eight authorized directors; Paul elected July 7, 2026, with term expiring at the 2027 annual meeting.
Paul's initial grant is restricted stock units valued at $350,000, or 89,058 units, vesting in roughly equal annual installments over three years.
Outside directors also receive an annual award valued at $175,000 under the policy, and Paul signed the standard director and officer indemnification agreement.
Paul previously served on the boards of Allot Ltd., ON24, Inc. and DSP Group, Inc.
Shawn Morris resigned from Privia Health Group's Board of Directors and its Compliance Committee, effective immediately, on July 6, 2026. The company said the resignation was not due to any disagreement over its operations, policies, or practices.
Resignation effective July 6, 2026, with immediate effect
Morris left the Board and the Compliance Committee of the Board
Company states no disagreement on operations, policies, or practices
Lifeway Foods entered into a Master Security Agreement with its current lender, CIBC Bank USA, on June 30, 2026, providing up to $22,000,000 in loan advances to finance or refinance equipment purchases. Advances convert into a five-year Equipment Guidance Line Note once the interim funding period ends, and the existing credit agreement terms remain unchanged. The filing describes a borrowing arrangement rather than an operating result, so it does not directly show a change in Lifeway's earnings.
Up to $22,000,000 in aggregate loan advances available during an interim funding period expiring June 30, 2027
Interest payable monthly at 1-month SOFR plus 1.65%, both during the interim period and after conversion
Advances convert to the Equipment Guidance Line Note, payable in monthly installments and maturing five years after the Conversion Date
Existing Credit Agreement with Fresh Made, Inc. and Lifeway Wisconsin, Inc. remains unchanged
GSR V Acquisition Corp., a blank check company, said holders of its Public Units can separately trade Class A ordinary shares and rights starting July 2, 2026, under the tickers GSRV and GSRVR. Units not separated will keep trading as GSRVU. The change is administrative and does not alter the terms of the shares or rights, which convert into Class A ordinary shares only upon completion of an initial business combination.
Separate trading of Class A ordinary shares and rights begins July 2, 2026.
Each unit consists of one Class A ordinary share and one-seventh of one right; each whole right entitles the holder to one Class A ordinary share upon an initial business combination.
Separated shares and rights trade as GSRV and GSRVR on Nasdaq; unseparated units continue as GSRVU.
Holders must have brokers contact Odyssey Transfer and Trust Company, the transfer agent, to separate units.
Vor Biopharma director Andrew Levin resigned from the board effective immediately on July 6, 2026, and the company said the resignation was not due to any disagreement. On July 7, 2026, the board appointed David Zaccardelli, Pharm.D., a former pharmaceutical chief executive, to fill the vacancy as an independent Class II director. The change is a board-level administrative update with no stated effect on operations or financial results.
Andrew Levin, M.D., Ph.D. resigned as a director effective immediately; notice delivered July 6, 2026
David Zaccardelli, Pharm.D., 61, appointed July 7, 2026 as an independent Class II director, serving until the 2029 annual meeting
Zaccardelli receives a $40,000 annual cash retainer and an initial option grant of up to 68,000 shares or $700,000 in grant-date value, whichever is lower
Fiserv President Dhivya Suryadevara resigned for good reason effective July 7, 2026, and will remain a non-executive employee through July 31, 2026 to support an orderly transition. Andrew Gelb and Srini Krish were named interim leaders of the Financial Solutions business effective immediately, which shows the company is moving to fill the gap left by the departure.
Dhivya Suryadevara resigned as President on July 7, 2026, citing good reason under her offer letter and the company's executive severance policy.
Suryadevara stays on as a non-executive employee with current base salary and benefits through July 31, 2026.
Andrew Gelb (EVP and COO, Financial Solutions) and Srini Krish (Head of Technology and Operations, Financial Solutions) were appointed interim leaders effective immediately.
Farmers & Merchants Bancorp said its board decided on June 30, 2026 to appoint Gregory R. Allen to fill an open board seat, with his first meeting set for September 29, 2026. He will receive the same non-employee director pay as other board members, and the filing does not say which committees he will join.
Board appointed Gregory R. Allen to fill an open vacancy; decision made June 30, 2026
First board meeting for Mr. Allen scheduled for September 29, 2026
Director pay for 2026 includes a $50,000 to $75,000 cash retainer plus $17,500 in stock, depending on role
Filing states no family relationship with other directors or officers and no related-party transactions over $120,000 since the last fiscal year
CuriosityStream said it completed the acquisition of the remaining ownership interests in its German operations from its partners SPIEGEL TV and Autentic, giving it sole ownership of the market. The filing does not disclose a purchase price or financial effect, so the impact on results cannot be measured from this document.
Acquired remaining ownership interests from SPIEGEL TV and Autentic, announced July 7, 2026
Germany was previously run through a 2021 joint venture to expand the Curiosity brand across Germany, Austria and Switzerland
Saevar Lemke will continue as General Manager of the German operations
The filing gives no purchase price or financial terms
EchoStar and Hughes Satellite Systems disclosed that Hamid Akhavan, CEO of EchoStar Capital and President and CEO of Hughes, resigned effective immediately on July 6, 2026, following discussions with the board about a change in strategic direction. Charles W. Ergen will take over his responsibilities as Principal Executive Officer of Hughes, and EchoStar Capital will be folded into Corporate Development led by Thomas A. Cullen.
Hamid Akhavan resigned July 6, 2026 from all positions with EchoStar and Hughes, including his board seats, citing a change of strategic direction discussed with the board.
Akhavan will consult with the company through December 31, 2026 to ensure an orderly transition.
Charles W. Ergen takes over as Principal Executive Officer of Hughes; the filing refers to EchoStar's other filings for his compensation and related-party transactions.
Akhavan's option vesting is accelerated from December 31, 2026 to July 6, 2026; EchoStar Capital merges into Corporate Development under Thomas A. Cullen.
Capstone Energy+, Inc. said Nasdaq approved its application to list common stock, and the shares are expected to begin trading under the ticker CEPL on July 8, 2026, moving from OTC Markets. The company said existing shareholders need not take any action, and the filing reports no new financial results.
Nasdaq notified the company on June 30, 2026 that its listing application was approved.
Trading under CEPL is expected to begin July 8, 2026, replacing the OTCQX ticker CGEH.
The 8-K names the Nasdaq Global Market, while the press release names the Nasdaq Global Select Market.
Lazard, Inc. said director Andrew M. Alper retired from its Board, including all committees, effective July 7, 2026, and that Kathy Elsesser, a former Goldman Sachs partner, joined the Board the same day. Ms. Elsesser was also appointed to the Compensation Committee and will chair it once Mr. Alper's retirement takes effect. The filing describes the retirement as not the result of any disagreement with the company.
Andrew M. Alper retired from the Board and its committees, effective July 7, 2026, after more than 13 years of service.
Kathy Elsesser joined the Board effective July 7, 2026, after the Board elected her on July 2, 2026.
Ms. Elsesser joined the Compensation Committee and will chair it upon Mr. Alper's retirement.
Ms. Elsesser also serves on the Board of TPG Inc. and retired from the Goldman Sachs Partnership in 2023.
SAB Biotherapeutics announced that Breakthrough T1D has awarded a grant to Michael J. Haller, M.D., University of Florida, to support the PRISE-hATG clinical study of SAB-142 in patients with Stage 3 type 1 diabetes who are 100 days to 2 years from diagnosis. SAB BIO will co-fund the study, which extends its clinical evaluation of SAB-142 beyond the Phase 2b SAFEGUARD trial; the filing gives no financial amount for the grant or the company's share of costs.
Breakthrough T1D awarded the grant to Michael J. Haller, M.D., Professor and Chief of Pediatric Endocrinology at the University of Florida, dated July 7, 2026.
PRISE-hATG evaluates SAB-142 in patients 100 days to 2 years from a Stage 3 T1D diagnosis.
SAB BIO will co-fund the study alongside the complementary Phase 2b SAFEGUARD trial.
The filing does not disclose grant or co-funding amounts.
Digi Power X reported that its Alabama AI data center buildout is on schedule, that it has secured commitments for all major long-lead equipment for Phase 1, and that it is finalizing project-level financing. The company said it had approximately $155 million in cash and no long-term debt as of July 3, 2026, and it set fiscal 2027 targets of an annualized run rate of approximately $250–$300 million.
Cash and cash equivalents of approximately $155 million and no long-term debt as of July 3, 2026
Approximately $95 million of capital deployed into the Alabama site year to date, funded from internal resources
Phase 1 targeted for ready-for-service in December 2026; Phase 2 expected online by the end of the first fiscal quarter of 2027
Fiscal 2027 target of an annualized run rate of approximately $250–$300 million across three segments
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.